Vous êtes ici

NeonMind Bioscience Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
NEON
Indice CSE: 
Devise: 

The Issuer is engaged in preclinical research to develop potential clinical treatments and wellness products to address obesity and weight management conditions and to promote health and wellness. The Issuer operates three divisions: (i) a pharmaceutical division engaged in drug development of psychedelic compounds with two lead psilocybin-based drug candidates targeting obesity; and (ii) a medical services division focused on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings. 

Vous êtes ici

NeonMind Bioscience Inc. (NEON)

SEDAR Information

Information d'entreprise

Addresse
Suite 200, 1238 Homer St
Vancouver, BC V6B2Y5
Canada
Téléphone
1 866-811-8960
Courriel
info@neonmind.com
URL
http://www.neonmind.com
Date d’inscription à la cote
Lundi, janvier 4, 2021
Agent de transfert
Endeavor Trust Corporation
Vérificateur
Saturna Group Chartered Professional Accountants LLP

Advertisement

Publicité

Capitalisation

Capitalisation: 
128,275,430
Réservé à l'émission: 
148,800,000

Bulletins

29/12/2020

2020-1238 - Nouvelles inscriptions - Neonmind Biosciences Inc. (NEON)

Le 29 decembre/December 2020

The common shares of Neonmind Biosciences Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

The Issuer is conducting research into potentially therapeutic uses of compounds found in psychedelic mushrooms and is commercializing edible mushroom infused beverages. 

Advertisement

Publicité

Latest CSE News

Évènements à venir

2022-01-25-Jamaica-Stock-Exchange-Conference_Website.png

17th Regional Investments & Capital Markets Conference 2022

Mardi, janvier 25, 2022 (Jour entier) - Jeudi, janvier 27, 2022 (Jour entier)
VRIC_1200x675.jpg

Vancouver Resource Investment Conference (VRIC)

Mardi, mai 17, 2022 - 08:30 - Mercredi, mai 18, 2022 - 17:30